Related Experiment Video
Updated: Apr 3, 2026
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Treatment of Retinoblastoma in 2015: Agreement and Disagreement
David H Abramson1, Carol L Shields2, Francis L Munier3
1Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Ophthalmology, Weill-Cornell Medical Center, New York, New York.
Abstract:
The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have completely replaced external beam radiotherapy, reduced the use of systemic chemotherapy, and diminished enucleations by 90% without evidence of compromising patient survival.
Related Concept Videos
01:20The Retinoblastoma Gene
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:56Treatment Resistant Cancers
02:56Treatment Resistent Cancers